Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib rollover study for patients benefiting after prior Novartis nilotinib trials
2012-003902-28Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nilotinib in gastrointestinal stromal tumor (GIST), sponsored by Novartis. Started Jan 2013; status: completed.
02
Drugs
nilotinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on 2012-003902-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003902-28.